BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28462692)

  • 1. The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature.
    Diamantis E; Kyriakos G; Quiles-Sanchez LV; Farmaki P; Troupis T
    Curr Cardiol Rev; 2017; 13(3):209-216. PubMed ID: 28462692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance.
    Biasucci LM; Biasillo G; Stefanelli A
    Clin Chem Lab Med; 2010 Dec; 48(12):1685-91. PubMed ID: 20868311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
    Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gender difference in hipolipemic and anti-inflammatory effects of statins in diabetics with coronary artery disease].
    Djindjić B; Ranković G; Zivić M; Savić T; Spasić M; Bubanj M
    Vojnosanit Pregl; 2009 Dec; 66(12):966-72. PubMed ID: 20095516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
    Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
    Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease.
    Marschang P; Friedrich GJ; Ditlbacher H; Stoeger A; Nedden DZ; Kirchmair R; Dienstl A; Pachinger O; Patsch JR
    Int J Cardiol; 2006 Jan; 106(2):183-90. PubMed ID: 16321690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off' atorvastatin for short time intervals.
    Thomas MK; Narang D; Lakshmy R; Gupta R; Naik N; Maulik SK
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):37-44. PubMed ID: 16534549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins: potential new indications in inflammatory conditions.
    Endres M
    Atheroscler Suppl; 2006 Apr; 7(1):31-5. PubMed ID: 16503422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of C-reactive protein levels among patients with stable coronary artery disease and on statin therapy.
    Blum A; Costello R; Samsel L; Zalos G; McCoy P; Csako G; Waclawiw MA; Cannon RO
    Isr Med Assoc J; 2009 Oct; 11(10):602-5. PubMed ID: 20077946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of systemic inflammation with local inflammatory activity in non-culprit lesions: beneficial effect of statins.
    Toutouzas K; Drakopoulou M; Markou V; Karabelas I; Vaina S; Vavuranakis M; Tsiamis E; Tsioufis C; Androulakis A; Stefanadis C
    Int J Cardiol; 2007 Jul; 119(3):368-73. PubMed ID: 17258821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of increased temperature of the culprit lesion after recent myocardial infarction: the favorable effect of statins.
    Toutouzas K; Vaina S; Tsiamis E; Vavuranakis M; Mitropoulos J; Bosinakou E; Toutouzas P; Stefanadis C
    Am Heart J; 2004 Nov; 148(5):783-8. PubMed ID: 15523307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
    Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
    Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy.
    Shishehbor MH; Aviles RJ; Brennan ML; Fu X; Goormastic M; Pearce GL; Gokce N; Keaney JF; Penn MS; Sprecher DL; Vita JA; Hazen SL
    JAMA; 2003 Apr; 289(13):1675-80. PubMed ID: 12672736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preprocedural statin therapy, inflammation, and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation.
    Greque GV; Serrano CV; Strunz CM; Soeiro A; Santos M; Pivateli F; Jacob JL; Pesaro AE; Nicolau JC; Kalil-Filho R
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):222-9. PubMed ID: 23592528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
    Piechota W; Piechota W
    Pol Merkur Lekarski; 2005 May; 18(107):511-5. PubMed ID: 16161944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of statin therapy on plasma markers of inflammation in patients without vascular disease.
    Ky B; Rader DJ
    Clin Cardiol; 2005 Feb; 28(2):67-70. PubMed ID: 15757075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease.
    Michalsen A; Lehmann N; Pithan C; Knoblauch NT; Moebus S; Kannenberg F; Binder L; Budde T; Dobos GJ
    Eur J Clin Nutr; 2006 Apr; 60(4):478-85. PubMed ID: 16306923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.